Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04804566 · ClinicalTrials.gov registry record
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
A clinical trial, sponsored by Amicus Therapeutics.
- Completed
- Registry status
- 44
- Enrollment target
NCT04804566 is a clinical trial that has completed, run by Amicus Therapeutics. The registered enrollment target is 44 participants.
The verdict
NCT04804566 has completed, sponsored by Amicus Therapeutics.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The objective of this study is to increase the understanding surrounding the choices presented to patients and families impacted by Fabry disease.
Interventions
- OTHER This is a non-interventional study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2023-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04804566
The ClinicalTrials.gov registry entry for NCT04804566 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amicus Therapeutics, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which This is a non-interventional study is the first listed.
NCT04804566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04804566 about?
NCT04804566 is a clinical study titled "Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients". The objective of this study is to increase the understanding surrounding the choices presented to patients and families impacted by Fabry disease.
What is the current status of trial NCT04804566?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2023-03-01. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT04804566?
The interventions under investigation include: This is a non-interventional study (OTHER).
Who is sponsoring clinical trial NCT04804566?
This trial is sponsored by Amicus Therapeutics, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.